Biomedicum Helsinki

Last updated
Biomedicum Helsinki
Established2001 (Building 1)
2008 (Building 2)
Research typeMedical research and teaching center
Location 60°11′26″N24°54′21″E / 60.19056°N 24.90583°E / 60.19056; 24.90583
Affiliations
Website www.biomedicum.fi

Biomedicum Helsinki, building 1 Biomedicum Helsinki.JPG
Biomedicum Helsinki, building 1

The Biomedicum Helsinki is a research and teaching center located in the Meilahti district of Helsinki, Finland. It contains two buildings (Biomedicum Helsinki 1 and 2), and features research and teaching facilities of the University of Helsinki's Faculty of Medicine, the Helsinki University Central Hospital, the EMBL Nordic partner Finnish Institute for Molecular Medicine, [1] the Folkhälsan Research Center, the Minerva Foundation Institute for Medical Research, the Wihuri Research Institute, and several companies in the life science field.[ citation needed ]

Building 1 was completed in 2001 [2] and Building 2 in 2008. [3] A bridge named in honor of Konrad ReijoWaara (1853-1936), a prominent figure in the Medical Association Duodecim and the first editor-in-chief of the magazine of the same name, [4] connects the buildings. The use of the buildings are coordinated by the Biomedicum Helsinki Foundation, which also funds research activities in the field of medicine.[ citation needed ]

References

  1. ↑ 195331@au.dk. "About the Nordic EMBL Partnership" . Retrieved 2 April 2020.{{cite web}}: CS1 maint: numeric names: authors list (link)
  2. ↑ Aho, Kaija (6 April 2000). "Biomedicum antaa tilat lääketieteelle". Helsingin Sanomat. Retrieved 2 April 2020.
  3. ↑ Liiten, Marjukka (11 March 2006). "Molekyylilääketieteen keskus Helsingin yliopistoon". Helsingin Sanomat. Retrieved 2 April 2020.
  4. ↑ "Duodecim; lääketieteellinen aikakauskirja. - NLM Catalog - NCBI". NLM Catalog. Retrieved 2 April 2020.


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.